Skip to main content

NewEdge Advisors, LLC

Position in NBIX — Neurocrine Biosciences Inc

CIK 1633516 NEW ORLEANS, LA

Position in NBIX

as of Jun 30, 2026 · filed Aug 12, 2026
Position Value
$2,126,806
+$405,492 QoQ
Shares Held
12,619
-3.4% QoQ
Ownership
0.012%
of shares outstanding
% of Portfolio
0.01%
of 13F equity value
Holder Rank
#306
of 768 holders
Holding Since
Dec 2022
15 quarters on record
Voting authority Sole 1% Shared 0% None 99%

Common Shares in NBIX Over Time

Shares Held

Position Value (USD)

Position in Drug Manufacturers - Specialty & Generic

Healthcare · as of Jun 30, 2026

NewEdge Advisors, LLC holds $12,323,215 across 27 Drug Manufacturers - Specialty & Generic names. NBIX ranks #2 (17.3% of the industry book) .

# Ticker Company Shares Value (USD) Open
2 NBIX
Neurocrine Biosciences Inc
This page
12,619 $2,126,806

All Filings in NBIX

Export CSV
15 filing rows on record
Report Date Value (USD) Shares
2026-06-30 $2,126,806 12,619
2026-03-31 $1,721,314 13,066
2025-12-31 $1,843,506 12,998
2025-09-30 $1,730,323 12,326
2025-06-30 $1,347,773 10,723
2025-03-31 $843,878 7,630
2024-12-31 $666,529 4,883
2024-09-30 $582,091 5,052
2024-06-30 $425,813 3,093
2024-03-31 $397,209 2,880
2023-12-31 $59,555 452
2023-09-30 $5,400 48
2023-06-30 $4,526 48
2023-03-31 $46,662 461
2022-12-31 $1,664,396 13,935